Scott Barclay

Curative is a leading healthcare services company that created and launched the first-of-its-kind employer-based health insurance plan. Founded in 2020 by CEO Fred Turner and CTO Isaac Turner, Curative reimagined health insurance by providing unmatched simplicity, enhanced engagement, and cost transparency with a competitive monthly premium and $0 out-of-pocket costs.* We currently serve employers headquartered in Georgia, Florida and Texas, with plans to expand. Members can be located and access our network nationwide. Curative holds an AM Best rating of A- three years in a row. For more information on Curative, visit www.curative.com, subscribe to our newsletter at curative.com/subscribe, or follow us on Facebook, Instagram, Twitter, and LinkedIn. *To qualify, members need to complete a Baseline Visit within 120 days of the plans effective date **Please be aware of counterfeit/fake job postings and profiles using different aliases that fraudulently allege to be from Curative. All job postings and correspondence will be sourced via Curative Inc. We will never ask you for any sort of payment nor will we ever conduct interviews via text message. If you have received or suspect any similar activity attributed to Curative, please report it at www.ic3.gov and contact abuse@curative.com directly for further assistance.

Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease. To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures. A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.

Carbon Health is a health technology company and modern healthcare provider that simplifies access to care through its EHR platform, locations with urgent and primary services, and patient app for easier everyday health.

Enzyme’s mission is to automate and simplify life science regulatory approval and compliance. We reduce your cost of compliance and help bring your cutting-edge technology to market faster. Our cloud based Quality Management System (QMS) streamlines documentation and integrates with tools you are already using. And our experts guide you through your entire regulatory and compliance lifecycle: from pre-submission, to product design and development, regulatory submission, and post-market compliance. Enzyme supports all life science companies, with an emphasis on companies making digital health, or software as a medical device (SaMD), products.

Primer exists to make the world a safer place. We do this by building trusted decision-ready AI for the world's most critical organizations. Our software enables leaders, operators, and analysts to better understand the changing world around us in real time, and make informed decisions when the stakes are high.

Subtle Medical is a medical imaging software company. Our goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose. We use the state-of-art proprietary deep learning AI algorithms to renovate the radiology workflow to deliver faster, safer and smarter imaging for imaging providers and the patients they serve.

ServiceNow AI Research: shaping the future of work with AI At ServiceNow, we’re putting AI to work for people. As an AI-native company, ServiceNow sees agentic AI as a defining step in how enterprises will work with intelligent systems, moving from passive assistants to active digital coworkers. We believe AI should not just support the enterprise: it should act as an adaptive partner that can continuously learn, plan, and provide meaningful assistance in complex enterprise environments. Our goal is to help organizations across every industry transform through intelligent, scalable, and human-centered AI solutions, always guided by trust, responsibility, and impact. Who we are ServiceNow AI Research is a passionate team of scientists, researchers, and innovators dedicated to advancing the state of the art in enterprise AI. We bridge frontier research and real-world applications to ensure that every ServiceNow user benefits from intelligent, scalable, and trustworthy AI-driven experiences. Our mission aligns scientific excellence with business impact, unlocking the next generation of enterprise intelligence. Our commitment to ethics and open-source innovation As an AI-native company, responsibility is built into everything we do. At ServiceNow, we believe AI must be developed with fairness, transparency, and accountability, values that guide our work and commitment to building trustworthy enterprise AI. We are also dedicated to advancing AI through open-source contributions, fostering accessibility, collaboration, and continuous innovation within the global AI community.

CarePort is the leading care coordination network with thousands of providers connected across the U.S. The end-to-end platform bridges acute and post-acute EHR data, providing visibility into the entire patient journey for providers, physicians, payers and ACOs. With CarePort, healthcare professionals can efficiently and effectively coordinate patient care to better manage patients as they move through the continuum. CarePort helps providers meet and comply with the patient event notification Condition of Participation, as part of the CMS Interoperability and Patient Access final rule, and the IMPACT Act.

Propeller Health is a precision digital health company on a mission to uplift every person living with chronic disease so they can take control of their health and live a better life. We power motivating, care-connected patient journeys and unify value for all stakeholders – providers, payers, pharma, and other healthcare and life sciences organizations. The Propeller Platform includes FDA-cleared and CE-marked medical devices, consumer apps, support and coaching, and secure access to clinical data for provider monitoring. Our precision approach is designed to motivate behavior change and track patient adherence with the goals of enabling medication optimization and helping predict costly exacerbations. In more than 150 peer-reviewed abstracts and publications, our digital-first chronic respiratory care platform has demonstrated improved quality of life and clinical outcomes while lowering healthcare costs. As a wholly owned subsidiary of ResMed, Propeller brings broad respiratory care expertise, digital therapeutic coverage, and scale globally.

Elation Health is the most trusted technology platform for high-value primary care. Since 2010, the company has delivered clinical-first solutions — built on a collaborative EHR platform — that help practices start, grow, communicate, and succeed in delivering the highest-quality personalized care to patients. Elation Health supports primary care clinicians in upholding the craft of medicine while thriving in an evolving healthcare landscape. Today, Elation Health serves 32,000 clinicians caring for millions of Americans.

To achieve more precise care for every patient, we need to transform real-world evidence into insights that can directly impact care. At Syapse, that is real-world care. It’s found in the way we empower healthcare organizations to work together in active, transparent partnerships, delivering complete patient insights to answer the questions that matter and then purposefully applying it at where patients receive care – driving real impact for cancer patients and beyond.

In 2022, Lumiatas assets were acquired by Somatus, the nation’s leading and largest value-based kidney care company.

Insight Partners is a global software investor partnering with high-growth technology, software, and Internet startup and ScaleUp companies that are driving transformative change in their industries. As of December 31, 2025, the firm has over $90B in regulatory assets under management. Insight Partners has invested in more than 900 companies worldwide and has seen over 55 portfolio companies achieve an IPO. Headquartered in New York City, Insight has a global presence with leadership in London, Tel Aviv, and the Bay Area. Insight’s mission is to find, fund, and work successfully with visionary executives, providing them with tailored, hands-on software expertise along their growth journey, from their first investment to IPO. For more information on Insight and all its investments, visit insightpartners.com or follow us on X @insightpartners.

Point72 Ventures is a global venture capital strategy led by a diverse set of domain experts with the capital and mandate to lead rounds through all stages of a companys growth, from idea to IPO. Our team invests in founders with bold ideas who use the latest technologies to drive transformational change across industries, and offers entrepreneurs access to expertise and insights, executive and technical talent, and hands-on support. We are primarily based in New York, Seattle, and San Francisco. Point72 Ventures is an affiliate of Point72, the global asset manager founded by Steven A. Cohen. For more information, visit p72.vc.

Curative is a leading healthcare services company that created and launched the first-of-its-kind employer-based health insurance plan. Founded in 2020 by CEO Fred Turner and CTO Isaac Turner, Curative reimagined health insurance by providing unmatched simplicity, enhanced engagement, and cost transparency with a competitive monthly premium and $0 out-of-pocket costs.* We currently serve employers headquartered in Georgia, Florida and Texas, with plans to expand. Members can be located and access our network nationwide. Curative holds an AM Best rating of A- three years in a row. For more information on Curative, visit www.curative.com, subscribe to our newsletter at curative.com/subscribe, or follow us on Facebook, Instagram, Twitter, and LinkedIn. *To qualify, members need to complete a Baseline Visit within 120 days of the plans effective date **Please be aware of counterfeit/fake job postings and profiles using different aliases that fraudulently allege to be from Curative. All job postings and correspondence will be sourced via Curative Inc. We will never ask you for any sort of payment nor will we ever conduct interviews via text message. If you have received or suspect any similar activity attributed to Curative, please report it at www.ic3.gov and contact abuse@curative.com directly for further assistance.

Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease. To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures. A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.

Carbon Health is a health technology company and modern healthcare provider that simplifies access to care through its EHR platform, locations with urgent and primary services, and patient app for easier everyday health.